EFTRW

eFFECTOR Therapeutics, Inc. Warrant
EFTRW

Delisted

EFTRW was delisted on the 2nd of July, 2024.

Back to rankings

38 hedge funds and large institutions have $5.23M invested in eFFECTOR Therapeutics, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 4 increasing their positions, reducing their positions, and 4 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $
Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$294K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$229K
2
+$162K
3
+$133K
4
Citadel Advisors
Citadel Advisors
Florida
+$97.5K
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$90.1K

Top Sellers

1
-$170K
2
-$102K
3
-$26.9K
4
SCM
Saba Capital Management
New York
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.27M
2
$1.08M
3
$316K
4
$283K
5
$201K
6
$200K
7
$200K
8
$164K
9
$142K
10
$133K
11
$117K
12
$108K
13
$100K
14
$100K
15
$100K
16
$94K
17
$67K
18
$67K
19
$67K
20
$65K
21
$63K
22
$45K
23
$38K
24
$33K
25
$33K
1
2